Item request has been placed!
×
Item request cannot be made.
×
Processing Request
Item request has been placed!
×
Item request cannot be made.
×
Processing Request
-
Authors :
Tanaka T; Department of Antibody Drug Development, Tohoku University Graduate School of Medicine, 2-1 Seiryo-machi, Aoba-ku, Sendai 980-8575, Miyagi, Japan.; Suzuki H
Subjects: Antibodies, Monoclonal*/Antibodies, Monoclonal*/Antibodies, Monoclonal*/pharmacology ; Antibodies, Monoclonal*/Antibodies, Monoclonal*/Antibodies, Monoclonal*/therapeutic use ; Membrane Glycoproteins*/Membrane Glycoproteins*/Membrane Glycoproteins*/immunology
-
Source:
Cells [Cells] 2024 Nov 06; Vol. 13 (22). Date of Electronic Publication: 2024 Nov 06.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101600052 Publication Model: Electronic Cited Medium: Internet ISSN: 2073-4409
Record details
-
Authors :
Ye W; Department of Hematology, West China Hospital, Sichuan University, Chengdu, No.37 GuoXue Xiang, Chengdu, 610041, Sichuan Province, China.; Wu X
Subjects: ADP-ribosyl Cyclase 1/ADP-ribosyl Cyclase 1/ADP-ribosyl Cyclase 1/*antagonists & inhibitors ; Antibodies, Monoclonal/Antibodies, Monoclonal/Antibodies, Monoclonal/*therapeutic use ; Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/*therapeutic use
-
Source:
BMC cancer [BMC Cancer] 2021 Sep 06; Vol. 21 (1), pp. 994. Date of Electronic Publication: 2021 Sep 06.Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407
Record details
-
Authors :
Ukaji T; Division of Experimental Chemotherapy, The Cancer Chemotherapy Center, Japanese Foundation for Cancer Research, Tokyo, Japan.; Takemoto A
Subjects: Antibodies, Monoclonal/Antibodies, Monoclonal/Antibodies, Monoclonal/*therapeutic use ; Antibodies, Neutralizing/Antibodies, Neutralizing/Antibodies, Neutralizing/*therapeutic use ; Antineoplastic Agents/Antineoplastic Agents/Antineoplastic Agents/*therapeutic use
-
Source:
Cancer science [Cancer Sci] 2021 Jun; Vol. 112 (6), pp. 2299-2313. Date of Electronic Publication: 2021 Apr 05.Publisher: Wiley Publishing on behalf of the Japanese Cancer Association Country of Publication: England NLM ID: 101168776 Publication Model: Print-Electronic
Record details
-
Authors :
Joher N; Assistance Publique-Hôpitaux de Paris AP-HP, Hôpital Universitaire Henri Mondor, Service de Néphrologie et Transplantation, Fédération Hospitalo-Universitaire (Innovative Therapy for Immune Disorders), Créteil, France.; Université Paris Est Créteil UPEC, Institut National de la Santé et de la Recherche Médicale INSERM U955, Institut Mondor de Recherche Biomédicale IMRB, Équipe 21, Créteil, France.
Subjects: Desensitization, Immunologic* ; Histocompatibility* ; Organ Transplantation*/Organ Transplantation*/Organ Transplantation*/adverse effects
-
Source:
Frontiers in immunology [Front Immunol] 2021 May 20; Vol. 12, pp. 688301. Date of Electronic Publication: 2021 May 20 (Print Publication: 2021).Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet
Record details
-
Authors :
Kim JW; Biopharmaceutical Chemistry Major, School of Applied Chemistry, Kookmin University, Seoul 02707, Korea.; Cho YB
Subjects: Antibodies, Monoclonal/Antibodies, Monoclonal/Antibodies, Monoclonal/*therapeutic use ; Antineoplastic Agents, Immunological/Antineoplastic Agents, Immunological/Antineoplastic Agents, Immunological/*therapeutic use ; Cell Membrane/Cell Membrane/Cell Membrane/*immunology
-
Source:
Cells [Cells] 2021 Mar 17; Vol. 10 (3). Date of Electronic Publication: 2021 Mar 17.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101600052 Publication Model: Electronic Cited Medium: Internet ISSN: 2073-4409
Record details